300 related articles for article (PubMed ID: 35145798)
1. Tumor-Induced Osteomalacia With Normal Fibroblast Growth Factor-23 (FGF23) and Idiopathic Hypercalciuria.
Velazquez-Navarro JA; Loya-Teruel E; Rios-Gomez M; Montes-Ramirez JE
Cureus; 2022 Jan; 14(1):e20893. PubMed ID: 35145798
[TBL] [Abstract][Full Text] [Related]
2. Tumor-induced osteomalacia.
Florenzano P; Gafni RI; Collins MT
Bone Rep; 2017 Dec; 7():90-97. PubMed ID: 29021995
[TBL] [Abstract][Full Text] [Related]
3. Induction of FGF23-related hypophosphatemic osteomalacia by alcohol consumption.
Hidaka N; Kato H; Koga M; Katsura M; Oyama Y; Kinoshita Y; Fukumoto S; Makita N; Nangaku M; Ito N
Bone Rep; 2021 Dec; 15():101144. PubMed ID: 34901334
[TBL] [Abstract][Full Text] [Related]
4. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
Arai R; Onodera T; Terkawi MA; Mitsuhashi T; Kondo E; Iwasaki N
BMC Musculoskelet Disord; 2017 Feb; 18(1):79. PubMed ID: 28193220
[TBL] [Abstract][Full Text] [Related]
5. Hiding in plain sight: Gene panel and genetic markers reveal 26-year undiagnosed tumor-induced osteomalacia of the rib concurrently misdiagnosed as X-linked hypophosphatemia.
Colazo JM; DeCorte JA; Gillaspie EA; Folpe AL; Dahir KM
Bone Rep; 2021 Jun; 14():100744. PubMed ID: 33490314
[TBL] [Abstract][Full Text] [Related]
6. Tumor-induced osteomalacia - a mystery illness beyond aches, pains, and depression.
Ni HJ; Clifton-Bligh R; Brzozowska MM
Endocr Regul; 2021 Sep; 55(3):163-168. PubMed ID: 34523297
[No Abstract] [Full Text] [Related]
7. Challenges in the management of tumor-induced osteomalacia (TIO).
Brandi ML; Clunie GPR; Houillier P; Jan de Beur SM; Minisola S; Oheim R; Seefried L
Bone; 2021 Nov; 152():116064. PubMed ID: 34147708
[TBL] [Abstract][Full Text] [Related]
8. Reports of 17 Chinese patients with tumor-induced osteomalacia.
Yu WJ; He JW; Fu WZ; Wang C; Zhang ZL
J Bone Miner Metab; 2017 May; 35(3):298-307. PubMed ID: 27085966
[TBL] [Abstract][Full Text] [Related]
9. Persistent phosphaturic mesenchymal tumor causing tumor-induced osteomalacia treated with image-guided ablation.
Horng JC; Van Eperen E; Tutton S; Singh R; Shaker JL; Wooldridge AN
Osteoporos Int; 2021 Sep; 32(9):1895-1898. PubMed ID: 33655402
[TBL] [Abstract][Full Text] [Related]
10. Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature.
Hu FK; Yuan F; Jiang CY; Lv DW; Mao BB; Zhang Q; Yuan ZQ; Wang Y
Chin J Cancer; 2011 Nov; 30(11):794-804. PubMed ID: 22035861
[TBL] [Abstract][Full Text] [Related]
11. Tumor-Induced Osteomalacia Localized and Excised After Pregnancy.
Sum M; Hoda ST; Rapp T; Zan E
AACE Clin Case Rep; 2021; 7(6):363-366. PubMed ID: 34765732
[TBL] [Abstract][Full Text] [Related]
12. Hypophosphatemia related to a neuro-endocrine tumor of the pancreas: A case report.
Pickering ME; Bouvier D; Puravet A; Soubrier M; Sapin V; Oris C
Clin Biochem; 2022 Jun; 104():62-65. PubMed ID: 35337828
[TBL] [Abstract][Full Text] [Related]
13. Tumor-induced osteomalacia treated with T12 tumor resection.
Mancini AJ; Sabet A; Nielsen GP; Parker JA; Schwab JH; Ward A; Wu JS; Malabanan AO
Endocrinol Diabetes Metab Case Rep; 2022 Dec; 2022():. PubMed ID: 36511458
[TBL] [Abstract][Full Text] [Related]
14. Ectopic expression of Klotho in fibroblast growth factor 23 (FGF23)-producing tumors that cause tumor-induced rickets/osteomalacia (TIO).
Kinoshita Y; Takashi Y; Ito N; Ikegawa S; Mano H; Ushiku T; Fukayama M; Nangaku M; Fukumoto S
Bone Rep; 2019 Jun; 10():100192. PubMed ID: 30627598
[TBL] [Abstract][Full Text] [Related]
15. Sinonasal hemangiopericytoma caused hypophosphatemic osteomalacia: A case report.
Li J; Huang Y; Yang F; Zhang Q; Chen D; Wang Q
Medicine (Baltimore); 2018 Dec; 97(52):e13849. PubMed ID: 30593185
[TBL] [Abstract][Full Text] [Related]
16. Ovarian cancer-related hypophosphatemic osteomalacia--a case report.
Lin HA; Shih SR; Tseng YT; Chen CH; Chiu WY; Hsu CY; Tsai KS
J Clin Endocrinol Metab; 2014 Dec; 99(12):4403-7. PubMed ID: 25181387
[TBL] [Abstract][Full Text] [Related]
17. Tumor-induced osteomalacia combined with increased bone resorption postoperatively: A case report.
Shi L; Tang M; Duan S; Deng F; Zhang Y; Yang J; Hu J
Medicine (Baltimore); 2023 Jul; 102(27):e34217. PubMed ID: 37417620
[TBL] [Abstract][Full Text] [Related]
18. X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment.
Kinoshita Y; Fukumoto S
Endocr Rev; 2018 Jun; 39(3):274-291. PubMed ID: 29381780
[TBL] [Abstract][Full Text] [Related]
19. Global guidance for the recognition, diagnosis, and management of tumor-induced osteomalacia.
Jan de Beur SM; Minisola S; Xia WB; Abrahamsen B; Body JJ; Brandi ML; Clifton-Bligh R; Collins M; Florenzano P; Houillier P; Imanishi Y; Imel EA; Khan AA; Zillikens MC; Fukumoto S
J Intern Med; 2023 Mar; 293(3):309-328. PubMed ID: 36511653
[TBL] [Abstract][Full Text] [Related]
20. New Therapies for Hypophosphatemia-Related to FGF23 Excess.
Athonvarangkul D; Insogna KL
Calcif Tissue Int; 2021 Jan; 108(1):143-157. PubMed ID: 32504139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
